UNICO AMERICAN CORP

2022 Q1 Form 10-Q Financial Statement

#000165495422003993 Filed on March 29, 2022

View on sec.gov

Income Statement

Concept 2022 Q1 2021 Q3 2021 Q2

Balance Sheet

Concept 2022 Q1 2021 Q3 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $9.472M $15.79M $1.879M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.961M $2.262M $2.226M
YoY Change -10.86% -78.03% -78.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $71.23M $85.60M $97.33M
YoY Change -25.42% 1.67% 10.98%
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $112.1M $136.6M $132.5M
YoY Change -17.32% 2.86% 1.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $1.343M $2.915M $2.265M
YoY Change -75.58% 21.46% -16.11%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $951.2K $969.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.343M $2.915M $2.265M
YoY Change -75.58% 21.46% -16.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.343M $2.915M $2.265M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $90.49M $104.4M $97.57M
YoY Change -8.88% 9.06% 28.38%
SHAREHOLDERS EQUITY
Retained Earnings $18.94M
YoY Change
Common Stock $3.798M $3.783M $3.772M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $21.62M $32.23M $34.95M
YoY Change
Total Liabilities & Shareholders Equity $112.1M $136.6M $132.5M
YoY Change -17.32% 2.86% 1.16%

Cashflow Statement

Concept 2022 Q1 2021 Q3 2021 Q2

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
unam Investment Maturity Period
InvestmentMaturityPeriod
6.9
CY2021Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
548000 USD
CY2020Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
798000 USD
CY2021Q3 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
3466331 USD
CY2020Q4 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
2548440 USD
CY2021Q3 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
3683154 USD
CY2020Q4 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
2746706 USD
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
2661690 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
200000 USD
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
78709190 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
83409694 USD
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5304863 shares
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
76847878 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
80071280 USD
CY2021Q3 us-gaap Investments
Investments
85602034 USD
CY2020Q4 us-gaap Investments
Investments
87154400 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
422949 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
1210243 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15790770 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3957980 USD
CY2021Q3 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
437058 USD
CY2020Q4 us-gaap Accrued Investment Income Receivable
AccruedInvestmentIncomeReceivable
402046 USD
CY2021Q3 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
3788047 USD
CY2020Q4 us-gaap Premiums Receivable At Carrying Value
PremiumsReceivableAtCarryingValue
3321337 USD
CY2021Q3 unam Reinsurance Recoverable On Paid Losses
ReinsuranceRecoverableOnPaidLosses
704757 USD
CY2020Q4 unam Reinsurance Recoverable On Paid Losses
ReinsuranceRecoverableOnPaidLosses
621307 USD
CY2021Q3 unam Reinsurance Recoverables On Un Paid Losses
ReinsuranceRecoverablesOnUnPaidLosses
24494179 USD
CY2020Q4 unam Reinsurance Recoverables On Un Paid Losses
ReinsuranceRecoverablesOnUnPaidLosses
22253642 USD
CY2021Q3 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
3055369 USD
CY2020Q4 us-gaap Deferred Policy Acquisition Costs
DeferredPolicyAcquisitionCosts
3503248 USD
CY2021Q3 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
0 USD
CY2020Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
8335017 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2262497 USD
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5304885 shares
us-gaap Premiums Earned Net Property And Casualty
PremiumsEarnedNetPropertyAndCasualty
21309130 USD
us-gaap Premiums Earned Net Property And Casualty
PremiumsEarnedNetPropertyAndCasualty
20805517 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
3783346 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
3771767 USD
CY2021Q3 us-gaap Insurance Investment Income
InsuranceInvestmentIncome
427244 USD
CY2020Q3 us-gaap Insurance Investment Income
InsuranceInvestmentIncome
477145 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2038415 USD
CY2021Q3 us-gaap Other Assets
OtherAssets
459895 USD
CY2020Q4 us-gaap Other Assets
OtherAssets
313363 USD
CY2021Q3 us-gaap Assets
Assets
136594606 USD
CY2020Q4 us-gaap Assets
Assets
131900755 USD
CY2021Q3 unam Unpaid Losses And Loss Adjustment Expenses
UnpaidLossesAndLossAdjustmentExpenses
78536895 USD
CY2020Q4 unam Unpaid Losses And Loss Adjustment Expenses
UnpaidLossesAndLossAdjustmentExpenses
74893509 USD
CY2021Q3 us-gaap Unearned Premiums
UnearnedPremiums
22770407 USD
CY2020Q4 us-gaap Unearned Premiums
UnearnedPremiums
18188298 USD
CY2021Q3 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
143940 USD
CY2020Q4 us-gaap Deposit Contracts Liabilities
DepositContractsLiabilities
208538 USD
CY2021Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
2915133 USD
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
3577450 USD
CY2021Q3 us-gaap Liabilities
Liabilities
104366375 USD
CY2020Q4 us-gaap Liabilities
Liabilities
96867795 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5304863 shares
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
1470436 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
2637347 USD
CY2021Q3 us-gaap Retained Earnings Unappropriated
RetainedEarningsUnappropriated
26974449 USD
CY2020Q4 us-gaap Retained Earnings Unappropriated
RetainedEarningsUnappropriated
28623846 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
32228231 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
35032960 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
136594606 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
131900755 USD
CY2021Q3 us-gaap Premiums Earned Net Property And Casualty
PremiumsEarnedNetPropertyAndCasualty
7737622 USD
CY2020Q3 us-gaap Premiums Earned Net Property And Casualty
PremiumsEarnedNetPropertyAndCasualty
7124272 USD
us-gaap Insurance Investment Income
InsuranceInvestmentIncome
1470846 USD
us-gaap Insurance Investment Income
InsuranceInvestmentIncome
1487335 USD
CY2021Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
57173 USD
CY2020Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
38214 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
218982 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
39789 USD
CY2021Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 USD
CY2020Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 USD
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 USD
CY2021Q3 us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
147722 USD
CY2020Q3 us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
19670 USD
us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
18559 USD
us-gaap Unrealized Gain On Securities
UnrealizedGainOnSecurities
42629 USD
CY2021Q3 us-gaap Other Operating Income
OtherOperatingIncome
95330 USD
CY2020Q3 us-gaap Other Operating Income
OtherOperatingIncome
74784 USD
us-gaap Other Operating Income
OtherOperatingIncome
123044 USD
us-gaap Other Operating Income
OtherOperatingIncome
278544 USD
CY2021Q3 unam Total Insurance Company Revenues
TotalInsuranceCompanyRevenues
8169647 USD
CY2020Q3 unam Total Insurance Company Revenues
TotalInsuranceCompanyRevenues
7734085 USD
unam Total Insurance Company Revenues
TotalInsuranceCompanyRevenues
26834419 USD
CY2020Q3 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
461540 USD
unam Total Insurance Company Revenues
TotalInsuranceCompanyRevenues
22653814 USD
CY2021Q3 us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
385548 USD
us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
1234720 USD
us-gaap Insurance Commissions And Fees
InsuranceCommissionsAndFees
1388494 USD
CY2021Q3 us-gaap Interest And Fee Income Loans Commercial
InterestAndFeeIncomeLoansCommercial
40458 USD
CY2020Q3 us-gaap Interest And Fee Income Loans Commercial
InterestAndFeeIncomeLoansCommercial
56985 USD
us-gaap Interest And Fee Income Loans Commercial
InterestAndFeeIncomeLoansCommercial
130228 USD
us-gaap Interest And Fee Income Loans Commercial
InterestAndFeeIncomeLoansCommercial
191690 USD
CY2021Q3 us-gaap Interest Income Other
InterestIncomeOther
5 USD
CY2020Q3 us-gaap Interest Income Other
InterestIncomeOther
7076 USD
us-gaap Interest Income Other
InterestIncomeOther
541 USD
us-gaap Interest Income Other
InterestIncomeOther
7096 USD
CY2021Q3 us-gaap Revenues
Revenues
8595648 USD
CY2020Q3 us-gaap Revenues
Revenues
8259686 USD
us-gaap Revenues
Revenues
28199908 USD
us-gaap Revenues
Revenues
24241094 USD
CY2021Q3 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
6851898 USD
CY2020Q3 us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
17320051 USD
us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
18521818 USD
us-gaap Policyholder Benefits And Claims Incurred Net
PolicyholderBenefitsAndClaimsIncurredNet
28086342 USD
CY2021Q3 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
1951053 USD
CY2020Q3 us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
1279703 USD
us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
4078563 USD
us-gaap Deferred Policy Acquisition Cost Amortization Expense
DeferredPolicyAcquisitionCostAmortizationExpense
3626154 USD
CY2021Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
1171944 USD
CY2020Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2584478 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
3505665 USD
us-gaap Labor And Related Expense
LaborAndRelatedExpense
4958900 USD
CY2021Q3 us-gaap Insurance Commissions
InsuranceCommissions
20022 USD
CY2020Q3 us-gaap Insurance Commissions
InsuranceCommissions
23235 USD
us-gaap Insurance Commissions
InsuranceCommissions
61024 USD
us-gaap Insurance Commissions
InsuranceCommissions
73190 USD
CY2021Q3 us-gaap Other General Expense
OtherGeneralExpense
1051350 USD
CY2020Q3 us-gaap Other General Expense
OtherGeneralExpense
1398135 USD
us-gaap Other General Expense
OtherGeneralExpense
3371952 USD
us-gaap Other General Expense
OtherGeneralExpense
3372483 USD
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
11046267 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
22605602 USD
us-gaap Costs And Expenses
CostsAndExpenses
29539022 USD
us-gaap Costs And Expenses
CostsAndExpenses
40117069 USD
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2450619 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14345916 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1339114 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-15875975 USD
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
59579 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3594572 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
310191 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3543153 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2510198 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-17940488 USD
us-gaap Net Income Loss
NetIncomeLoss
-1649305 USD
us-gaap Net Income Loss
NetIncomeLoss
-19419128 USD
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.47
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.66
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5304863 shares
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5305742 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5304878 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5306068 shares
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2510198 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-17940488 USD
us-gaap Net Income Loss
NetIncomeLoss
-19419128 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
37089779 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
54997754 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-243365 USD
us-gaap Net Income Loss
NetIncomeLoss
-1649305 USD
us-gaap Net Income Loss
NetIncomeLoss
-19419128 USD
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-224132 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
35792 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1166911 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1438101 USD
CY2021Q3 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-2734330 USD
CY2020Q3 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-17904696 USD
us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-2816216 USD
us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-17981027 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
55080325 USD
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-9519 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1438101 USD
CY2020Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-3279 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
35792 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-17940488 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
37089779 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
35032960 USD
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-102 USD
us-gaap Share Based Compensation
ShareBasedCompensation
11589 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1166911 USD
us-gaap Net Income Loss
NetIncomeLoss
-1649305 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
32228231 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
34950972 USD
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
11589 USD
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-224132 USD
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-2510198 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
32228231 USD
us-gaap Net Income Loss
NetIncomeLoss
-1649305 USD
us-gaap Net Income Loss
NetIncomeLoss
-19419128 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
416631 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
567639 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-16989 USD
us-gaap Share Based Compensation
ShareBasedCompensation
11589 USD
us-gaap Share Based Compensation
ShareBasedCompensation
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-165837 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
7139 USD
us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
-218982 USD
us-gaap Availableforsale Securities Gross Realized Gain Loss Excluding Other Than Temporary Impairments
AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments
-31635 USD
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-18559 USD
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
-42629 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-300873 USD
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
142703 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-35012 USD
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
0 USD
us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-2323987 USD
us-gaap Increase Decrease In Reinsurance Recoverable
IncreaseDecreaseInReinsuranceRecoverable
-8823570 USD
us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
447879 USD
us-gaap Increase Decrease In Deferred Policy Acquisition Costs
IncreaseDecreaseInDeferredPolicyAcquisitionCosts
635 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-146533 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
7373846 USD
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
6138690 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1160676 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
-2461690 USD
us-gaap Payments For Proceeds From Short Term Investments
PaymentsForProceedsFromShortTermInvestments
1996815 USD
us-gaap Proceeds From Sale Of Other Real Estate Heldforinvestment
ProceedsFromSaleOfOtherRealEstateHeldforinvestment
12028876 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-26428 USD
us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
3643386 USD
us-gaap Increase Decrease In Liability For Claims And Claims Adjustment Expense Reserve
IncreaseDecreaseInLiabilityForClaimsAndClaimsAdjustmentExpenseReserve
19267419 USD
us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
4582109 USD
us-gaap Increase Decrease In Unearned Premiums
IncreaseDecreaseInUnearnedPremiums
822093 USD
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-64598 USD
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
140991 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-662318 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
233990 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
310191 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
3543153 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-111442 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3634617 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
26757588 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
14757414 USD
us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
1841681 USD
us-gaap Payments To Acquire Available For Sale Securities Equity
PaymentsToAcquireAvailableForSaleSecuritiesEquity
1515228 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
23082609 USD
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
12318203 USD
us-gaap Proceeds From Sale Of Other Real Estate Heldforinvestment
ProceedsFromSaleOfOtherRealEstateHeldforinvestment
0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
640714 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
612907 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11944334 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3568159 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
102 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9518 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-102 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-9518 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
11832790 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-75976 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3957980 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5781639 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15790770 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5705663 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
8800 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
8800 USD
us-gaap Nature Of Operations
NatureOfOperations
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Unico American Corporation is an insurance holding company that underwrites property and casualty insurance through its insurance company subsidiary; provides property, casualty, and health insurance through its agency subsidiaries; and provides insurance premium financing and membership association services through its other subsidiaries. Unico American Corporation is referred to herein as the “<span style="text-decoration:underline">Company</span>” or “<span style="text-decoration:underline">Unico</span>” and such references include both the corporation and its subsidiaries, all of which are wholly owned. Unico was incorporated under the laws of Nevada in 1969.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">During the quarter ended September 30, 2021, Unico took actions to cause its subsidiary, Crusader, to enter into runoff. In connection with its runoff, Crusader began to cease writing new and renewal business and to wind down operations that support the writing of insurance policies. Crusader ceased writing any new insurance policies in September 2021 and will no longer renew policies after December 8, 2021. Crusader issues notices of non-renewal in accordance with the California Department of Insurance (“<span style="text-decoration:underline">CA DOI</span>”) rules and regulations for its existing in-force policies to terminate such policies at the expiration of the current policy periods. In August 2021, Unico also discontinued its premium financing operations formerly conducted through its subsidiary American Acceptance Corporation (“<span style="text-decoration:underline">AAC</span>”), which activity is reflected on the Statement of Operations under “Other insurance operations.”</p>
unam Concentration Of Risks
ConcentrationOfRisks
99.8
CY2021Q3 us-gaap Payments For Rent
PaymentsForRent
20000 USD
CY2021Q3 us-gaap Payments Of Dividends
PaymentsOfDividends
5000 USD
CY2021Q3 us-gaap Customer Funds
CustomerFunds
3100000 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
2452835 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
390567 USD
us-gaap Basis Of Accounting
BasisOfAccounting
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“<span style="text-decoration:underline">GAAP</span>”) for interim financial information and the instructions to Form 10‑Q and Rule 8-03 of Regulation S-X for smaller reporting companies. Accordingly, the condensed consolidated financial statements do not include all the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2021, are not necessarily indicative of the results that may be expected for the year ending December 31, 2021. Quarterly condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes in the Company’s 2020 Annual Report on Form 10-K as filed with the SEC on March 31, 2021.</p>
unam Gross Written Premium
GrossWrittenPremium
100
unam Gross Written Premium
GrossWrittenPremium
99.9
CY2021Q3 unam Concentration Of Risks
ConcentrationOfRisks
99.9
unam Concentration Of Risks
ConcentrationOfRisks
99.7
CY2020Q3 unam Concentration Of Risks
ConcentrationOfRisks
99.6
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with GAAP requires the Company to make estimates and assumptions that affect its reported amounts of assets and liabilities and its disclosure of any contingent assets and liabilities at the date of its financial statements, as well as its reported amounts of revenues and expenses during the reporting period. The most significant assumptions in the preparation of these condensed consolidated financial statements relate to losses and loss adjustment expenses. Actual results may differ significantly from the estimates used in preparing the condensed consolidated financial statements.</p>
unam Note2 Correction Of Immaterial Error In Previously Issued Financial Statements
Note2CorrectionOfImmaterialErrorInPreviouslyIssuedFinancialStatements
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">NOTE 2 - Correction of Immaterial Error in Previously Issued Financial Statements</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In the course of preparing the Company’s third quarter 2021 unaudited consolidated financial statements and as a result of the Independent Investigation as explained above in Note 1, the Company evaluated its historical disclosures related to restricted funds and restricted cash and identified certain errors in its historic audited annual and unaudited quarterly financial statements, as detailed in this Note 2. Based on consideration of both the quantitative and qualitative factors within the provisions of SEC Staff Accounting Bulletin No. 99, Materiality, and Staff Accounting Bulletin No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements, the Company determined that the errors detailed in this Note 2 were not material to its previously issued annual and interim condensed consolidated financial statements. Furthermore, the Company determined that correcting the errors in the third quarter of 2021 would not materially misstate its audited or unaudited condensed consolidated financial statements and therefore, no restatement of its prior period audited, or unaudited condensed consolidated financial statements was required. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Restricted Cash Disclosure</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Accounting Standards Codification (“<span style="text-decoration:underline">ASC</span>”) 230, Statement of Cash Flows, became effective in 2018, which required restricted cash to be included in the caption disclosures in the balance sheet and statements of cash flows and required restricted cash to be disclosed in a reconciliation of cash, cash equivalents and restricted cash. Accordingly, Note 2 to the Company’s 2020 annual audited financial statements (“<span style="text-decoration:underline">Note 2</span>”), which was titled “Cash and Cash Equivalents” should have been titled “Cash, Cash Equivalents and Restricted Cash” and references to “cash” elsewhere in Note 2 should include “cash and restricted cash.” Finally, the table included in Note 2 should have had an additional line item captioned “Restricted Cash,” and the amounts historically presented in the line item captioned “Cash and cash equivalents” should have been separated between the “Cash, Cash Equivalents, and Restricted Cash” line items. The December 31, 2020 disclosure should have been presented in the respective Annual Reports on Form 10-K:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:70%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Period Ended</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31</strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> </strong></p></td><td class="hdcell" colspan="2" style="width:9%;vertical-align:bottom;text-align:center;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>September 30 </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2021</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,747,737</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,367,821</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Restricted Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,210,243</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">422,949</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">3,957,980</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">15,790,770</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Restricted Funds Disclosure</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Note 1 to the Company’s historic annual audited financial statements (“<span style="text-decoration:underline">Note 1</span>”) disclosed a heading titled “Restricted Funds” with a tabular presentation and explanatory footnotes (the “<span style="text-decoration:underline">Note 1 Disclosure</span>”), which was included in the Note 1 Disclosure in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, and for prior fiscal year periods. The Note 1 Disclosure appears only in the Company’s Annual Reports on Form 10-K and does not appear in the Company’s Quarterly Reports on Form 10-Q. The Company determined that the Note 1 Disclosure was incorrectly presented in that (i) the amount presented as “Premium trust funds” did not reflect amounts actually held by Unifax as restricted trust funds in the account that was designated in Unico’s records as the “Unifax Premium Trust Account” (the “<span style="text-decoration:underline">Premium Trust Account</span>”); (ii) the footnote disclosure to the Note 1 table should have disclosed a deficiency (the “Premium Trust Account Deficiency”) in the amount of funds required to be held in trust by Unifax for the benefit of Crusader; and (iii) the footnote disclosure to the Note 1 table should have disclosed that the funds deposited into the Premium Trust Account were not held in separate accounts or segregated in accordance with the requirements of the California Insurance Code. Below is the Note 1 Disclosure as presented in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2020, followed by corrective disclosure.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0cm; text-align:justify;"><span style="text-decoration:underline">Restricted Funds</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Restricted funds are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:70%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> <strong>Year ended </strong></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td colspan="2" style="vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> </strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td colspan="2" style="BORDER-BOTTOM: #000000 1px solid;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Premium trust funds (1)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,595,135</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Assigned to state agencies (2)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">710,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Funds held as collateral (3)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">787,653</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total restricted funds</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">3,092,788</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(1)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">As required by law, the Company segregates from its operating accounts the premium collected from insureds that are payable to insurance companies into separate trust accounts.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(2)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$510,000 included in fixed maturity investments as of December 31, 2020, and $200,000 included in short-term investments as of December 31, 2020, are statutory deposits assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in states other than California.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(3)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Funds held as collateral by Comerica Bank &amp; Trust, N.A. (“Comerica”) included in available-for-sale fixed maturities pursuant to the reinsurance trust agreement among Crusader, United Specialty Insurance Company (“USIC”) and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance agreement with USIC.</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> <span style="text-decoration:underline">Restricted Funds</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> Restricted funds are as follows:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:70%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> <strong>Year ended</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 6.75pt; text-align:center;"><strong>December 31,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 6.75pt; text-align:center;"><strong> 2020</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Premium trust funds (1)(2)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,210,243</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Assigned to state agencies (3)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">998,000</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Funds held as collateral (4)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">787,653</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Total restricted funds</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 3px double;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 3px double;width:9%;vertical-align:bottom;text-align:right;">2,995,896</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:100%"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(1)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">The Company is required by law to segregate from its operating accounts the premium collected from insureds that are payable to insurance companies into separate trust accounts. As disclosed in further detail in Note 1 above under “Supervision Agreement” and “Independent Investigation,” during the year ended December 31, 2020. Unifax did not comply with the requirements of the California Insurance Code to hold such funds in separate accounts or segregate such funds in accordance with the CIC.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(2)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">At December 31, 2020, there was a deficiency (the “<span style="text-decoration:underline">Premium Trust Account Deficiency</span>”) in the amount of funds required to be held in trust by Unifax for the benefit of Crusader. The amount of the Premium Trust Account Deficiency was $1,595,135 at December 31, 2020<span style="text-decoration:underline">.</span></p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(3)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">$510,000 included in fixed maturity, and $200,000 included in short-term investments as of December 31, 2020 are statutory deposits assigned to and held by the California State Treasurer and the Insurance Commissioner of the State of Nevada. These deposits are required for writing certain lines of business in California and for admission in states other than California.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">(4)</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Funds held as collateral by Comerica Bank &amp; Trust, N.A. (“Comerica”) included in available-for-sale fixed maturities pursuant to the reinsurance trust agreement among Crusader, United Specialty Insurance Company (“USIC”) and Comerica to secure payment of Crusader’s liabilities and performance of its obligations under the reinsurance agreement with USIC.</p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:30px"> </p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><span style="text-decoration:underline">Premium Trust Account Deficiency Disclosure</span></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">  </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Additionally, a Premium Trust Account Deficiency should have been disclosed in the Company’s Quarterly Reports on Form 10-Q and the Year-End on Form 10-K. The following amounts should have been disclosed:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"> </p><table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:70%"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: #000000 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Premium Trust Deficiency</strong></p></td><td colspan="3" style="BORDER-BOTTOM: #000000 1px solid;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">September 30, 2021</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,452,835</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">December 31, 2020</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">1,595,135</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
1210243 USD
CY2021Q3 unam Cash Cash Equivalents And Restricted Cash
CashCashEquivalentsAndRestrictedCash
15790770 USD
CY2020Q4 unam Cash Cash Equivalents And Restricted Cash
CashCashEquivalentsAndRestrictedCash
3957980 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
2452835 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
1595135 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Premium
DebtInstrumentUnamortizedPremium
390567 USD
CY2020Q4 us-gaap Cash
Cash
2747737 USD
CY2021Q3 us-gaap Cash
Cash
15367821 USD
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
1210243 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
422949 USD
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3957980 USD
CY2021Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
15790770 USD
CY2020Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
1595135 USD
CY2020Q4 us-gaap Assets Designated To Closed Block Investments
AssetsDesignatedToClosedBlockInvestments
710000 USD
CY2020Q4 us-gaap Securities Held As Collateral At Fair Value
SecuritiesHeldAsCollateralAtFairValue
787653 USD
CY2020Q4 unam Restricted Funds
RestrictedFunds
3092788 USD
CY2020Q4 unam Statutory Deposit Assigned To California State Treasurer
StatutoryDepositAssignedToCaliforniaStateTreasurer
510000 USD
CY2020Q4 unam Statutory Deposit Held By Insurance Commission Of State Of Nevada
StatutoryDepositHeldByInsuranceCommissionOfStateOfNevada
200000 USD
CY2020Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
1595135 USD
CY2021Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
2452835 USD
CY2020Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
1595135 USD
unam Schedule Of Cash
ScheduleOfCash
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong> 2021</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong> </strong></p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31, </strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2020</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">15,367,821</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2,747,737</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Restricted cash</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">422,949</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">1,210,243</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 15px; text-align:left;">Total</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">15,790,770</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: black 1px solid;width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="BORDER-BOTTOM: black 1px solid;width:9%;vertical-align:bottom;text-align:right;">3,957,980</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2020Q4 us-gaap Cash
Cash
2747737 USD
CY2021Q3 us-gaap Restricted Cash
RestrictedCash
422949 USD
CY2021Q3 unam Shares Remaining For Repurchase Amount
SharesRemainingForRepurchaseAmount
4995406 USD
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10955661 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
10557080 USD
CY2020Q4 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
798000 USD
CY2020Q4 us-gaap Financial Instruments Owned Corporate Debt At Fair Value
FinancialInstrumentsOwnedCorporateDebtAtFairValue
46451905 USD
CY2020Q4 us-gaap Mortgage Backed Securities Available For Sale Fair Value Disclosure
MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure
26125608 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2830248 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2423617 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2262497 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2038415 USD
us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
over 39 years
CY2021Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
147463 USD
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
416631 USD
CY2020Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
190916 USD
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
567639 USD
CY2021Q3 us-gaap Capital Leases Income Statement Lease Revenue
CapitalLeasesIncomeStatementLeaseRevenue
0 USD
us-gaap Capital Leases Income Statement Lease Revenue
CapitalLeasesIncomeStatementLeaseRevenue
13806 USD
CY2020Q3 us-gaap Capital Leases Income Statement Lease Revenue
CapitalLeasesIncomeStatementLeaseRevenue
33325 USD
us-gaap Capital Leases Income Statement Lease Revenue
CapitalLeasesIncomeStatementLeaseRevenue
122684 USD
CY2021Q3 unam Building Operating Expenses Including Depreciation
BuildingOperatingExpensesIncludingDepreciation
77777 USD
unam Building Operating Expenses Including Depreciation
BuildingOperatingExpensesIncludingDepreciation
176483 USD
CY2020Q3 unam Building Operating Expenses Including Depreciation
BuildingOperatingExpensesIncludingDepreciation
200067 USD
unam Building Operating Expenses Including Depreciation
BuildingOperatingExpensesIncludingDepreciation
573100 USD
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
2326811 USD
CY2021Q3 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
7347117 USD
CY2021Q3 us-gaap Financial Instruments Owned Corporate Debt At Fair Value
FinancialInstrumentsOwnedCorporateDebtAtFairValue
47469519 USD
CY2021Q3 us-gaap Mortgage Backed Securities Available For Sale Fair Value Disclosure
MortgageBackedSecuritiesAvailableForSaleFairValueDisclosure
23892554 USD
CY2021Q3 us-gaap Certificates Of Deposit At Carrying Value
CertificatesOfDepositAtCarryingValue
548000 USD
CY2021Q3 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
3683154 USD
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
2661690 USD
CY2021Q3 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
85602034 USD
CY2020Q4 us-gaap Us Government Securities At Carrying Value
USGovernmentSecuritiesAtCarryingValue
10832181 USD
CY2020Q4 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
2746706 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
200000 USD
CY2020Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
87154400 USD
CY2021Q3 unam Net Unrealized Investment Gains On Equity Securities
NetUnrealizedInvestmentGainsOnEquitySecurities
-147722 USD
CY2020Q3 unam Net Unrealized Investment Gains On Equity Securities
NetUnrealizedInvestmentGainsOnEquitySecurities
19670 USD
CY2021Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
466099 USD
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
510119 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1581733 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
1588096 USD
CY2021Q3 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
38855 USD
CY2020Q3 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
32974 USD
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
110887 USD
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
100761 USD
CY2021Q3 unam Investment Income Net Of Investment Expenses
InvestmentIncomeNetOfInvestmentExpenses
427244 USD
CY2020Q3 unam Investment Income Net Of Investment Expenses
InvestmentIncomeNetOfInvestmentExpenses
477145 USD
unam Investment Income Net Of Investment Expenses
InvestmentIncomeNetOfInvestmentExpenses
1470846 USD
unam Investment Income Net Of Investment Expenses
InvestmentIncomeNetOfInvestmentExpenses
1487335 USD
CY2021Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
57173 USD
CY2020Q3 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
38214 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
218982 USD
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
39789 USD
CY2021Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 USD
CY2020Q3 us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 USD
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
3693858 USD
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
0 USD
unam Net Unrealized Investment Gains On Equity Securities
NetUnrealizedInvestmentGainsOnEquitySecurities
18559 USD
unam Net Unrealized Investment Gains On Equity Securities
NetUnrealizedInvestmentGainsOnEquitySecurities
42629 USD
CY2021Q3 unam Net Invest Inc Realzd Invest Gains Losses Unrealzd Invest Losses On Equities
NetInvestIncRealzdInvestGainsLossesUnrealzdInvestLossesOnEquities
336695 USD
CY2020Q3 unam Net Invest Inc Realzd Invest Gains Losses Unrealzd Invest Losses On Equities
NetInvestIncRealzdInvestGainsLossesUnrealzdInvestLossesOnEquities
535029 USD
unam Net Invest Inc Realzd Invest Gains Losses Unrealzd Invest Losses On Equities
NetInvestIncRealzdInvestGainsLossesUnrealzdInvestLossesOnEquities
5402245 USD
unam Net Invest Inc Realzd Invest Gains Losses Unrealzd Invest Losses On Equities
NetInvestIncRealzdInvestGainsLossesUnrealzdInvestLossesOnEquities
1569753 USD
CY2021Q3 us-gaap Securities Held As Collateral At Fair Value
SecuritiesHeldAsCollateralAtFairValue
8584173 USD
CY2021Q3 unam Security Owned And Pledged As Collateral Cost
SecurityOwnedAndPledgedAsCollateralCost
8446981 USD
CY2021Q3 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
2062462 USD
CY2020Q4 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
3416535 USD
CY2021Q3 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
201150 USD
CY2020Q4 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
78121 USD
CY2021Q3 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
79257190 USD
unam Fixed Maturity Investments Weighted Average Yield
FixedMaturityInvestmentsWeightedAverageYield
0.0217 pure
CY2020Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
11070641 USD
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
80869280 USD
CY2020Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
84207694 USD
CY2020 unam Fixed Maturity Investments Weighted Average Yield
FixedMaturityInvestmentsWeightedAverageYield
0.0258 pure
CY2021Q3 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
76728586 USD
CY2021Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
77395878 USD
CY2021Q3 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
1861312 USD
CY2020Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
3338414 USD
CY2021Q3 unam Deferred Federal Tax Benefit Expense
DeferredFederalTaxBenefitExpense
-390876 USD
CY2020Q4 unam Deferred Federal Tax Benefit Expense
DeferredFederalTaxBenefitExpense
-701067 USD
CY2021Q3 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
1470436 USD
CY2020Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
2637347 USD
CY2020 unam Investment Maturity Period
InvestmentMaturityPeriod
8.0
CY2021Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
16026385 USD
CY2021Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
225669 USD
CY2021Q3 unam Securities In Unrealized Loss Position For Less Than12 Months
SecuritiesInUnrealizedLossPositionForLessThan12Months
50 pure
CY2021Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
1743678 USD
CY2021Q3 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
95185 USD
CY2021Q3 unam Securities In Unrealized Loss Position For More Than12 Months
SecuritiesInUnrealizedLossPositionForMoreThan12Months
6 pure
CY2020Q4 unam Securities In Unrealized Loss Position For More Than12 Months
SecuritiesInUnrealizedLossPositionForMoreThan12Months
0 pure
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue
6048661 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
115478 USD
CY2020Q4 unam Securities In Unrealized Loss Position For Less Than12 Months
SecuritiesInUnrealizedLossPositionForLessThan12Months
39 pure
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value
AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue
0 USD
CY2020Q4 us-gaap Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
0 USD
CY2021Q3 unam Sold Securities Number
SoldSecuritiesNumber
0 pure
CY2020Q3 unam Sold Securities Number
SoldSecuritiesNumber
6 pure
unam Sold Securities Number
SoldSecuritiesNumber
3 pure
unam Sold Securities Number
SoldSecuritiesNumber
7 pure
CY2021Q3 unam Sold Securities Amortized Cost
SoldSecuritiesAmortizedCost
0 USD
CY2020Q3 unam Sold Securities Amortized Cost
SoldSecuritiesAmortizedCost
-2923386 USD
unam Sold Securities Amortized Cost
SoldSecuritiesAmortizedCost
2193393 USD
unam Sold Securities Amortized Cost
SoldSecuritiesAmortizedCost
3524702 USD
CY2021Q3 unam Sold Securities Realized Gain Loss
SoldSecuritiesRealizedGainLoss
0 USD
CY2020Q3 unam Sold Securities Realized Gain Loss
SoldSecuritiesRealizedGainLoss
30057 USD
unam Sold Securities Realized Gain Loss
SoldSecuritiesRealizedGainLoss
710 USD
unam Sold Securities Realized Gain Loss
SoldSecuritiesRealizedGainLoss
31171 USD
CY2021Q3 unam Called Securities Number
CalledSecuritiesNumber
4 pure
CY2020Q3 unam Called Securities Number
CalledSecuritiesNumber
1 pure
unam Called Securities Number
CalledSecuritiesNumber
7 pure
unam Called Securities Number
CalledSecuritiesNumber
-3 pure
CY2021Q3 unam Called Securities Amortized Costs
CalledSecuritiesAmortizedCosts
2929834 USD
CY2020Q3 unam Called Securities Amortized Costs
CalledSecuritiesAmortizedCosts
249998 USD
unam Called Securities Amortized Costs
CalledSecuritiesAmortizedCosts
5323613 USD
unam Called Securities Amortized Costs
CalledSecuritiesAmortizedCosts
1949536 USD
CY2021Q3 unam Called Securities Realized Gain Loss Other
CalledSecuritiesRealizedGainLossOther
-166 USD
CY2020Q3 unam Called Securities Realized Gain Loss Other
CalledSecuritiesRealizedGainLossOther
2 USD
unam Called Securities Realized Gain Loss Other
CalledSecuritiesRealizedGainLossOther
-18613 USD
unam Called Securities Realized Gain Loss Other
CalledSecuritiesRealizedGainLossOther
464 USD
CY2021Q3 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
3466331 USD
CY2020Q4 us-gaap Available For Sale Equity Securities Amortized Cost Basis
AvailableForSaleEquitySecuritiesAmortizedCostBasis
2548440 USD
CY2021Q3 us-gaap Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
216823 USD
CY2020Q4 us-gaap Available For Sale Equity Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleEquitySecuritiesAccumulatedGrossUnrealizedLossBeforeTax
198266 USD
CY2021Q3 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
3683154 USD
CY2020Q4 us-gaap Available For Sale Securities Equity Securities
AvailableForSaleSecuritiesEquitySecurities
2746706 USD
CY2021Q3 unam Brokered Certificates Of Deposit
BrokeredCertificatesOfDeposit
548000 USD
CY2020Q4 unam Brokered Certificates Of Deposit
BrokeredCertificatesOfDeposit
798000 USD
CY2021Q3 unam Certificates Of Deposit Held By States
CertificatesOfDepositHeldByStates
300000 USD
CY2020Q4 unam Certificates Of Deposit Held By States
CertificatesOfDepositHeldByStates
200000 USD
CY2021Q3 unam Short Term Investments Held By State
ShortTermInvestmentsHeldByState
200000 USD
CY2020Q4 unam Short Term Investments Held By State
ShortTermInvestmentsHeldByState
200000 USD
CY2021Q3 unam State Held Deposits
StateHeldDeposits
500000 USD
CY2020Q4 unam State Held Deposits
StateHeldDeposits
400000 USD
CY2021Q3 unam Short Term Us Treasury Bills
ShortTermUSTreasuryBills
1499822 USD
CY2020Q4 unam Short Term Us Treasury Bills
ShortTermUSTreasuryBills
0 USD
CY2021Q3 us-gaap Short Term Borrowings
ShortTermBorrowings
961868 USD
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2021Q3 unam Short Term Certificates Of Deposit
ShortTermCertificatesOfDeposit
200000 USD
CY2020Q4 unam Short Term Certificates Of Deposit
ShortTermCertificatesOfDeposit
200000 USD
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
2661690 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
200000 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
11756705 USD
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
17118968 USD
us-gaap Payments For Losses And Loss Adjustment Expense
PaymentsForLossesAndLossAdjustmentExpense
17442347 USD
CY2021Q3 us-gaap Liability For Claims And Claims Adjustment Expense Property Casualty Liability
LiabilityForClaimsAndClaimsAdjustmentExpensePropertyCasualtyLiability
54042716 USD
CY2020Q4 us-gaap Liability For Claims And Claims Adjustment Expense Property Casualty Liability
LiabilityForClaimsAndClaimsAdjustmentExpensePropertyCasualtyLiability
74893509 USD
CY2019Q4 us-gaap Liability For Claims And Claims Adjustment Expense Property Casualty Liability
LiabilityForClaimsAndClaimsAdjustmentExpensePropertyCasualtyLiability
55066480 USD
CY2020Q4 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
22253642 USD
CY2019Q4 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
14725855 USD
CY2020Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
52639867 USD
CY2019Q4 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
40340625 USD
unam Provision For Insured Events Of Current Year
ProvisionForInsuredEventsOfCurrentYear
20529747 USD
unam Provision For Insured Events Of Current Year
ProvisionForInsuredEventsOfCurrentYear
19925024 USD
unam Development Of Insured Events Of Prior Years
DevelopmentOfInsuredEventsOfPriorYears
-2007929 USD
unam Development Of Insured Events Of Prior Years
DevelopmentOfInsuredEventsOfPriorYears
8161318 USD
unam Incurred Losses And Loss Adjustment Expenses
IncurredLossesAndLossAdjustmentExpenses
18521818 USD
unam Incurred Losses And Loss Adjustment Expenses
IncurredLossesAndLossAdjustmentExpenses
28086342 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
5455432 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1
5685642 USD
us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1
11663536 USD
CY2020Q3 us-gaap Liability For Claims And Claims Adjustment Expense Property Casualty Liability
LiabilityForClaimsAndClaimsAdjustmentExpensePropertyCasualtyLiability
50984620 USD
CY2021Q3 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
24494179 USD
CY2020Q3 us-gaap Reinsurance Recoverable For Unpaid Claims And Claims Adjustments
ReinsuranceRecoverableForUnpaidClaimsAndClaimsAdjustments
23349279 USD
CY2021Q3 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
78536895 USD
CY2020Q3 us-gaap Liability For Unpaid Claims And Claims Adjustment Expense Net
LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet
74333899 USD
CY2021Q3 unam Additional Paid
AdditionalPaid
276000 USD
CY2020Q4 unam Additional Paid
AdditionalPaid
120000 USD
unam Loss Adjustment Expenses
LossAdjustmentExpenses
500000 USD
us-gaap Business Acquisition Equity Interest Issued Or Issuable Description
BusinessAcquisitionEquityInterestIssuedOrIssuableDescription
to increase the adjusted capital above 300% and to address the actions that Crusader will take to correct the conditions
unam Description Of Underwriting Losses
DescriptionOfUnderwritingLosses
as of December 31, 2021, is less than 300%, an additional Company Action Level Event was triggered as the statutory accounting basis combined ratio as of December 31, 2021, is 133%. At September 30, 2021, Crusader’s statutory accounting basis combined ratio was 122%. Crusader’s statutory accounting basis combined ratio was 132% as of December 31, 2021
CY2020 unam Net Income Losses
NetIncomeLosses
46498960 USD
unam Net Income Losses
NetIncomeLosses
23068041 USD
CY2021 unam Net Income Losses
NetIncomeLosses
22494454 USD
CY2021Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
3100000 USD
CY2021Q3 us-gaap Assets Held In Trust
AssetsHeldInTrust
2452835 USD
CY2022Q1 us-gaap Assets Held In Trust
AssetsHeldInTrust
178707 USD
us-gaap Liquidation Date1
LiquidationDate1
2023-01-31
unam Description
Description
The non-qualified stock options granted under the Plan in 2021 vest 25% on the first anniversary of the grant date and 25% annually thereafter on the anniversary date and expire four years after the date of the grant. The restricted stock grants granted under the Plan in 2021 vest 100% on the fourth anniversary of the grant date
us-gaap Share Based Compensation
ShareBasedCompensation
11589 USD
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4.52
us-gaap Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
0.0000 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.7501 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0005 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.1000 pure
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
44250000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
4.52
unam Weighted Average Remaining Contactual Life Outstanding Beginning Balance
WeightedAverageRemainingContactualLifeOutstandingBeginningBalance
P4Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
48000000 shares
unam Weighted Average Remaining Contactual Life Outstanding Ending Balance
WeightedAverageRemainingContactualLifeOutstandingEndingBalance
P4Y
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
92250000 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
4.52
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y9M14D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 USD
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 USD
us-gaap Operations Commenced Date1
OperationsCommencedDate1
2022-02-01

Files In Submission

Name View Source Status
0001654954-22-003993-index-headers.html Edgar Link pending
0001654954-22-003993-index.html Edgar Link pending
0001654954-22-003993.txt Edgar Link pending
0001654954-22-003993-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
unam-20210930.xsd Edgar Link pending
unam-20210930_cal.xml Edgar Link unprocessable
unam-20210930_def.xml Edgar Link unprocessable
unam-20210930_lab.xml Edgar Link unprocessable
unam-20210930_pre.xml Edgar Link unprocessable
unam_10q.htm Edgar Link pending
unam_10q_htm.xml Edgar Link completed
unam_ex311.htm Edgar Link pending
unam_ex312.htm Edgar Link pending
unam_ex321.htm Edgar Link pending
unam_ex322.htm Edgar Link pending